Dual Vasopressin Receptor Antagonism to Improve Congestion in Patients With Acute Heart Failure: Design of the AVANTI Trial-Reference-Cited by-同舟云学术

Dual Vasopressin Receptor Antagonism to Improve Congestion in Patients With Acute Heart Failure: Design of the AVANTI Trial

Published:2021-02 Issue:2 Volume:27 Page:233-241
ISSN:1071-9164
Container-title:Journal of Cardiac Failure
language:en
Short-container-title:Journal of Cardiac Failure

Author:

Goldsmith Steven R.,Burkhoff Daniel^ORCID,Gustafsson Finn,Voors Adriaan,Zannad Faiez,Kolkhof Peter^ORCID,Staedtler Gerald,Colorado Pablo,Dinh Wilfried,Udelson James E.

Funder

Bayer

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference38 articles.

1. Congestion in acute heart failure syndromes: an essential target of evaluation and treatment;Gheorghiade;Am J Med,2006

2. The vulnerable phase after hospitalization for heart failure;Greene;Nat Rev Cardiol,2015

3. Prevalence, predictors and clinical outcome of residual congestion in acute decompensated heart failure;Rubio-Gracia;Int J Cardiol,2018

4. Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure: activation of the neurohumoral axis;Francis;Ann Intern Med,1985

5. Loop diuretics in acute decompensated heart failure: necessary? Evil? A necessary evil?;Felker;Circ Heart Fail,2009

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Copeptin associates with major adverse cardiovascular events in patients on maintenance hemodialysis;Clinica Chimica Acta;2025-01

2. Are you giving men with heart failure the best care?;Trends in Urology & Men's Health;2024-01

3. Metabolic effects of vasopressin in pathophysiology of diabetic kidney disease;Frontiers in Endocrinology;2023-09-18

4. Targeting G protein‐coupled receptors for heart failure treatment;British Journal of Pharmacology;2023-06-16

5. Vasopressin receptor antagonists: a patent summary (2018-2022);Expert Opinion on Therapeutic Patents;2023-05-04